Consistent Export Growth: 17.65% CAGR Over 7 Years
India's exports under HSN Sub-Chapter 3001 have grown at a compound annual rate of 17.65% over 7 fiscal years, rising from ₹179.60 Crore in FY 2018-19 to ₹476.17 Crore in FY 2024-25.
HSN Sub Chapter 3001 represents Organotherapeutic extracts & heparin under GST classification. This code helps businesses identify Organotherapeutic extracts & heparin correctly for billing, taxation, and trade purposes. With HSN Sub Chapter 3001, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import/export of Organotherapeutic extracts & heparin.
Join our guided walkthrough to see how BUSY can transform your business operations.
GST Rate for Organotherapeutic extracts & heparin under HSN Code 3001. Understand current tax rates, exemptions, and legal classifications to ensure accurate billing and GST filing.
Chapter No
30HSN Code
HSN Description
Glands and other organs for organotherapeutic uses, dried,whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included
New GST Rate
Old GST Rate
Following tariff HSN codes fall under Organotherapeutic extracts & heparin.
Tariff HSN
Description
Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included glands and other organs, dried, whether or not powdered : pancreatin and dried powder of pancreas
Tariff HSN
Description
Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included glands and other organs, dried, whether or not powdered : other : powdered
Tariff HSN
Description
Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included glands and other organs, dried, whether or not powdered : other : other
Tariff HSN
Description
Extracts of glands or other organs or of their secretions : Liquid extracts of liver
Tariff HSN
Description
Extracts of glands or other organs or of their secretions : Liver extracts, dry
Tariff HSN
Description
Extracts of glands or other organs or of their secretions : Snake venom
Tariff HSN
Description
Extracts of glands or other organs or of their secretions : Other
Tariff HSN
Description
Other : Of human origin
Tariff HSN
Description
Other : Other : Heparin and its salts
Tariff HSN
Description
Other : Other : Other
India’s Exports
FY 2024-25₹476 Cr
0.0129% of India’s total exports
India’s Imports
FY 2024-25₹528 Cr
0.0087% of India’s total imports
Trade Balance
FY 2024-25−₹52 Cr
Surplus rank #675 of 1233 subchapters
% of Chapter 30
FY 2024-250.23%
Share of Chapter 30’s total exports in FY 2024-25
Import side: 2.09% of Chapter 30’s imports
Rank Within Chapter 30
FY 2024-25#6 of 6
Position by export value among subchapters in Chapter 30
Import-side rank: #5 of 6
At a glance
17.65%
Export CAGR
FY 2018-19 → FY 2024-25 · 7 fiscal years
#539
National Export Rank
of 1233 subchapters by export value, FY 2024-25
+80.33%
Peak Growth Year
FY 2019-20 · strongest single-year move
0.23%
Contribution to Ch. 30
Share of Chapter 30 exports in FY 2024-25
7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.
Balance
−207.49
Exports
179.60 ₹ Cr
0.0078% share
— YoY
0.17% of Ch. 30
Imports
387.09 ₹ Cr
0.0108% share
— YoY
2.65% of Ch. 30
Balance
−118.40
Exports
323.88 ₹ Cr
0.0147% share
+80.33% YoY
0.28% of Ch. 30
Imports
442.28 ₹ Cr
0.0132% share
+14.26% YoY
2.68% of Ch. 30
Balance
−401.05
Exports
543.00 ₹ Cr
0.0252% share
+67.65% YoY
0.38% of Ch. 30
Imports
944.05 ₹ Cr
0.0324% share
+113.45% YoY
4.99% of Ch. 30
Balance
−70.17
Exports
962.83 ₹ Cr
0.0307% share
+77.32% YoY
0.67% of Ch. 30
Imports
1,033.00 ₹ Cr
0.0226% share
+9.42% YoY
4.03% of Ch. 30
Balance
+101.92
Exports
855.63 ₹ Cr
0.0236% share
−11.13% YoY
0.54% of Ch. 30
Imports
753.71 ₹ Cr
0.0131% share
−27.04% YoY
3.59% of Ch. 30
Balance
+312.67
Exports
880.80 ₹ Cr
0.0243% share
+2.94% YoY
0.48% of Ch. 30
Imports
568.13 ₹ Cr
0.0101% share
−24.62% YoY
2.65% of Ch. 30
Balance
−51.99
Exports
476.17 ₹ Cr
0.0129% share
−45.94% YoY
0.23% of Ch. 30
Imports
528.16 ₹ Cr
0.0087% share
−7.04% YoY
2.09% of Ch. 30
CAGR · 7-Year
Exports
17.65% /yr
Imports
5.32% /yr
reference, FY 2024-25
Export
₹2,08,128.62 Cr
Import
₹25,224.54 Cr
Trade Balance
+1,82,904.08
India's exports under HSN Sub-Chapter 3001 have grown at a compound annual rate of 17.65% over 7 fiscal years, rising from ₹179.60 Crore in FY 2018-19 to ₹476.17 Crore in FY 2024-25.
In FY 2024-25, HSN Sub-Chapter 3001 ranks #539 out of 1233 subchapters by total export value. Within Chapter 30, it ranks #6 of 6. By trade surplus, it ranks #675 of 1233.
The strongest single-year export movement for HSN Sub-Chapter 3001 was recorded in FY 2019-20, when exports surged by 80.33% over the prior year.
In FY 2024-25, India's imports of ₹528.16 Cr exceeded exports of ₹476.17 Cr, resulting in a trade deficit of ₹51.99 Crore — ranking #675 of 1233 by surplus magnitude.
India's imports under HSN Sub-Chapter 3001 have grown at 5.32% CAGR, reaching ₹528.16 Crore in FY 2024-25.
Among the 6 subchapters under Chapter 30, HSN Sub-Chapter 3001 ranks #6 by export value — accounting for 0.23% of the chapter's total exports in FY 2024-25. On the import side, it holds 2.09% share (rank #5).
BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.
Clear answers to common queries about HSN Sub Chapter 3001 and GST compliance.
It includes Organotherapeutic extracts & heparin
Generate an e‑way bill when the consignment value exceeds ₹50,000, unless exempted for the transaction. E‑invoicing depends on turnover (AATO threshold as notified) for B2B supplies, not on the item itself.
Yes. Many food/agri goods are treated differently when sold as pre‑packaged & labelled retail packs versus loose/open packs. If Organotherapeutic extracts & heparin is sold in small pouches (e.g., 500 g) with an MRP and label, record that on the invoice. Loose bulk bags often follow a different treatment.
Using a broad or incorrect HSN, ignoring material/form (e.g., raw vs processed), or mixing goods and services on one line. Always match wording to the HSN Notes and keep a classification working paper.
Prefer separate lines per item with its HSN so each component follows its own tax treatment. If it is a naturally bundled supply, identify the principal supply and tax the whole bundle accordingly.
The composition scheme is optional for eligible small suppliers of goods. You cannot issue tax invoices or collect tax under composition. Check turnover limits and exclusions; evaluate margins and ITC loss before opting in.